| (CAD) | Dec 2024 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -2.60M | 45.29% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RKV.V returned -61.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +95.0% |
| 1 year | -61.8% |
| 5 years | -87.8% |
| All-time high | $2.20 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RKV.V would be worth today ›No. Rakovina Therapeutics Inc. has not paid a dividend in the past 12 months.
Rakovina Therapeutics Inc. is part of the Healthcare sector.
Rakovina Therapeutics Inc. has a market cap of 4.76M CAD, based on the latest quote.
Rakovina Therapeutics Inc. is expected to report earnings around Aug 27, 2026. That date is an estimate and has not been confirmed by the company.
